Blood Test that  Redefining Early Alzheimer’s Detection
 
Catch early signs of Alzheimer’s and cognitive decline years before symptoms appear.
 
The test identify early signs of memory decline long before severe symptoms appear.
 
Early detection offers meaningful benefits for managing cognitive changes related to Alzheimer’s disease.
Identifying these early signals gives you and your loved ones the time and clarity to make informed decisions, plan for the future, and access the right medical guidance and support. By understanding your brain health sooner, you gain a proactive advantage in protecting memory and overall cognitive wellness.
 
Test reports on associations in the following areas:
 
Neurodegenerative disorders – mild cognitive decline & late onset Alzheimer’s disease
Mood disorders – Depressive disorder, bipolar disorder, anxiety disorder & post-traumatic stress disorder
Addictive behaviour – Risk for alcohol, nicotine, cannabis & opioid dependence, psychosis response from cannabis use, eating disorders (binge eating), adrenaline seeking’/risk-taking behaviour
 
Neuropsychiatric disorders account for up to 25% of all disability-adjusted life years (Gatt et al 2015.). Whilst the heritability of these mental disorders is significant, environmental factors also play a key role in their aetiology. Genetic variations involved in key biological processes that contribute toward the risk of development of mental health disorders may give insight to the prevention, diagnosis and treatment of the disease.
The test analyses 30 genes which have been shown to have significant associations with key mental health disorders.
 
Clinical Value
Knowledge of an individual’s genotype will provide diagnostic insight and assist in determining optimal treatment strategies for individuals suffering from, or at risk for, mental health disorders.
Genes included in the test are involved in key biological areas related to mental health. These areas include:
 
Lipid metabolism
Inflammation
Methylation
Neurotrophic, dopaminergic & serotonergic pathways
Endo-cannabinoid pathway
Cell-signalling
 
The  Report Provides:
 
Identification of the level of impact of any genetic variants
An explanation of their impact on the specific biochemical area
An explanation of each area’s impact on mental health